16 Nov

Baxter International: Analysts Remain Bullish on the Stock

WRITTEN BY Kenneth Smith

Analysts’ recommendations

In November, among the 17 analysts covering Baxter International (BAX), ten analysts recommended a “buy” or a higher rating, five recommended a “hold” rating, and three recommended a “sell” rating. The mean rating for Baxter International stock is 2.29 with a target price of $73.27, which implies an upside potential of 11.3% over Baxter International’s closing price of $65.83 on November 15.

Baxter International: Analysts Remain Bullish on the Stock

Peer ratings

Analysts have given Abbott Laboratories (ABT), Boston Scientific (BSX), and Johnson & Johnson (JNJ) a mean rating of 1.8, 1.52, and 2.32, respectively, and target prices of $78.94, $41.96, and $146.78, respectively.

Baxter International’s enterprise value is $36.32 billion, while its enterprise value-to-revenues ratio is 3.28. The stock is trading at a forward PE multiple of 20.13x. Baxter International’s price-to-sales ratio is 3.19, while its price-to-book value ratio is 3.85. Abbott Laboratories, Boston Scientific, and Johnson & Johnson’s price-to-book value ratios stand at 4.05, 6.09, and 6.0, respectively.

Baxter International’s current ratio, a metric of how effectively a company can meet its short-term obligations, stands at 2.60. Abbott Laboratories, Boston Scientific, and Johnson & Johnson’s current ratios are 1.40, 0.80, and 1.70, respectively.

Baxter International’s cash per share stands at $5.34. Abbott Laboratories, Boston Scientific, and Johnson & Johnson’s cash per share are $4.29, $0.12, and $7.22, respectively.

Latest articles

US crude oil production has more than doubled since 2009 and grew by 1.1% over the last year. Currently, there are 133 operable refineries in the US.

The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.

Higher revenues, increased ticket prices, and lower fuel costs are likely to drive American Airlines' Q3 earnings higher despite its Boeing MAX woes.

HEXO plans to report its Q4 earnings before the market opens on October 24. October has been tough for Hexo, with its stock falling 31.2% as of October 18.

Today, Advanced Micro Devices (AMD) rose 4% to over $32, making it one of the top Nasdaq gainers. Morgan Stanley raised its price target for AMD stock.

Early in 2019, President Donald Trump warned that China could overtake the US as a global power. He vowed that this would not happen under his leadership.